3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Cardiotoxicity
6
Lymphoma, Non-Hodgkin
4
Lymphoma
3
Breast Neoplasms
3
Prostatic Neoplasms
2
Multiple Myeloma
2
Leukemia
2
Cardiovascular Diseases
2
Small Cell Lung Carcinoma
1
Obesity
1
Neoplasms
1
Neoplasm, Residual
1
Myelodysplastic Syndromes
1
Metastatic Solid Tumors
1
Metabolic Syndrome
1
Melanoma
1
Lymphoproliferative Disorders
1
Lymphomatoid Granulomatosis
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Primary Effusion
1
Lymphoma, Follicular
1
Lymphoma, B-Cell
1
Lymphoma, AIDS-Related
1
Lung Neoplasms
1
Leukemia, Hairy Cell
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Heart Failure
1
Epstein-Barr Virus Infections
1
Interventions
pembrolizumab
90
Blood Specimen Collection
41
Cyclophosphamide
37
Bevacizumab
36
Nivolumab
35
Standard of Care
32
Carboplatin
31
Surveys and Questionnaires
29
Paclitaxel
27
atezolizumab
25
Exercise
25
Pemetrexed
24
Gemcitabine
23
Cisplatin
23
Fluorouracil
22
Radiotherapy
20
Leucovorin
20
Dexamethasone
20
Docetaxel
19
Oxaliplatin
18
Rituximab
16
Irinotecan
16
Cetuximab
16
dostarlimab
15
Drug Therapy
15
Doxorubicin
15
Ipilimumab
14
Biopsy
14
130-nm albumin-bound paclitaxel
14
fludarabine
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neoplasms
×
Echocardiography
×
1 year
×
Clear all
NCT05201014
2025-09-05
CASCADE
Mayo Clinic
Active not recruiting
112 enrolled